MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Feasibility of using wearable sensors to monitor activity and sleep patterns in inpatients with delirium and Parkinson’s disease

    G. Bate, S. Richardson, JP. Taylor, D. Burn, L. Allan, A. Yarnall, Y. Guan, S. Del-Din, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To assess the feasibility of using wearable sensors in Parkinson's disease (PD) inpatients with/without delirium and to quantify clinically relevant digital outcomes to facilitate…
  • 2022 International Congress

    Monitoring disease course by sensor-based gait analysis: gait symmetry and motor impairment progression in Parkinson’s disease.

    F. Marxreiter, V. Koch, M. Regensburger, S. Stallforth, J. Jukic, J. Klucken, J. Winkler, H. Gassner (Erlangen, Germany)

    Objective: Evaluate gait symmetry index as progression marker for motor impairment in patients with Parkinson’s disease (PD). Background: PD is a neurodegenerative disease characterized by…
  • 2022 International Congress

    Conservative iron chelation for Neuroferritinopathy

    F. Marchand, C. Moreau, G. Kuchcinski, V. Huin, L. Defebvre, D. Devos (LILLE, France)

    Objective: Evaluate the safety and efficacy of a conservative mode of iron chelation with deferiprone 30 mg/kg/day in neuroferritinopathy to limit iron-related neurodegeneration and associated…
  • 2022 International Congress

    Repetitive Transcranial Magnetic Stimulation to the Inferior Parietal Lobule in Task-Specific Focal Hand Dystonia: A Randomized Crossover Blinded Outcome Assessment Study

    S. Bhadran, R. Rajan (South Delhi, India)

    Objective: We used repetitive transcranial magnetic stimulation to test the hypothesis that an inhibitory protocol to the left inferior parietal lobule in right-handed patients with…
  • 2022 International Congress

    Is there a role for safinamide in atypical parkinsonian syndromes?

    A. Silva, M. Rodrigues (Braga, Portugal)

    Objective: To search for possible benefits of safinamide in atypical parkinsonism. Background: Safinamide is a selective reversible monoamine oxidase-B inhibitor with both dopaminergic and glutamatergic…
  • 2022 International Congress

    Expanding the services of Neurogenetic Clinic – Lessons learnt from Cerebellar Ataxia cohort

    P. Ponger, D. Barel, A. Mory, A. Kurolap, A. Bar David, H. Feldman Baris, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: We present an overview of patients seen by our Neurogenetic Clinic since 2019, focusing on the cerebellar ataxia (CA) cohort. Background: Diagnostic yield of…
  • 2022 International Congress

    mGlu3 receptors in Parkinson’s disease as a candidate target for neuroprotective therapy: evidence from preclinical studies to human genetic.

    M. Alborghetti, L. Di Menna, V. Bruno, G. Battaglia, FE. Pontieri, E. Bianchini, M. Simmaco, M. Borro, F. Nicoletti (Rome, Italy)

    Objective: In a  toxicological model of mouse parkinsonism through chronic injection of MPTP, we examined whether the presence or absence of mGlu3 receptors affected neurodegeneration…
  • 2022 International Congress

    Spinal cord stimulation for gait problems in Parkinson´s disease: Long term report and placebo viability

    R. Carra, J. Menezes, T. Capato, K. Duarte, R. Cury (Sao Paulo, Brazil)

    Objective: In the present study we set out to report a very long-term follow-up period of spinal cord stimulation (SCS) for Parkinson's Disease (PD) patients…
  • 2022 International Congress

    Assessment of the long-term effects of STN-DBS on axial symptoms in PD patients through a standardized clinical-instrumental approach

    F. Cavallieri, I. Campanini, A. Gessani, V. Fioravanti, B. Damiano, S. Scaltriti, E. Bardi, M. Corni, F. Antonelli, V. Rispoli, G. Di Rauso, F. Cavalleri, M. Molinari, S. Contardi, E. Menozzi, S. Meletti, G. Biagini, E. Moro, C. Budriesi, A. Merlo, F. Valzania (Reggio Emilia, Italy)

    Objective: To evaluate the long-term effects of bilateral STN-DBS and levodopa on axial symptoms in PD patients and the possible correlations between speech and gait…
  • 2022 International Congress

    Dopamine neuron platform for screening molecular mechanisms and inhibitory drugs against alpha-synuclein aggregation

    S. Er, I. Hlushchuk, P. Chmielarz, A. Domanskyi, M. Airavaara (Helsinki, Finland)

    Objective: Optimization of a dopamine neuron based,in vitro platform is beneficial for studying molecular mechanisms of alpha-synuclein aggregation,and screening of inhibitory drugs and deducing their…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley